Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose

Updated on: February 01,2024 17

Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose

Updated on:February 01,2024 17

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on: February 01,2024 15

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on:February 01,2024 15

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF

Updated on: February 01,2024 16

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF

Updated on:February 01,2024 16

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs

Updated on: February 01,2024 14

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs

Updated on:February 01,2024 14

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

Updated on: February 01,2024 10

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

Updated on:February 01,2024 10

Can an annual blood test find cancer while it's curable?

by Lisa M. KriegerCredit: Unsplash/CC0 Public DomainDespite decades of effort in the war against cancer, screening tests are available for only five types of the disease, representing less than one-th

Updated on: February 01,2024 11

Can an annual blood test find cancer while it's curable?

by Lisa M. KriegerCredit: Unsplash/CC0 Public DomainDespite decades of effort in the war against cancer, screening tests are available for only five types of the disease, representing less than one-th

Updated on:February 01,2024 11

Researchers discover how to steer army of immune cells toward cancer

by University of Rochester Medical CenterhHER2 CAR-T cell assays and in vivo distribution. a. Gating strategy for detection of hHER2-CAR-T cells. A median of > 90% of mouse CD8 T cells transdu

Updated on: February 01,2024 19

Researchers discover how to steer army of immune cells toward cancer

by University of Rochester Medical CenterhHER2 CAR-T cell assays and in vivo distribution. a. Gating strategy for detection of hHER2-CAR-T cells. A median of > 90% of mouse CD8 T cells transdu

Updated on:February 01,2024 19

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Updated on: February 01,2024 10

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Updated on:February 01,2024 10

Drug approved to help young patients battle a rare cancer

by Cara Murez HealthDay ReporterChildren and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.The U.S. Food and Drug Administration has&n

Updated on: February 01,2024 19

Drug approved to help young patients battle a rare cancer

by Cara Murez HealthDay ReporterChildren and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.The U.S. Food and Drug Administration has&n

Updated on:February 01,2024 19

Deep in the bile ducts, researchers explore how cancer arises

by Leslie Orr,University of Rochester Medical CenterGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111253A Wilmot Cancer Institute scientist discovered how

Updated on: February 01,2024 16

Deep in the bile ducts, researchers explore how cancer arises

by Leslie Orr,University of Rochester Medical CenterGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111253A Wilmot Cancer Institute scientist discovered how

Updated on:February 01,2024 16

Researchers identify promising new target for drug-resistant breast and ovarian cancers

by Lisa Marshall, University of Colorado at BoulderGraphical abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.03.017CU Boulder researchers have discovered a protein's

Updated on: February 01,2024 12

Researchers identify promising new target for drug-resistant breast and ovarian cancers

by Lisa Marshall, University of Colorado at BoulderGraphical abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.03.017CU Boulder researchers have discovered a protein's

Updated on:February 01,2024 12

Study reveals extent of residual lung damage after COVID-19 hospitalization

by American Thoracic SocietyNew study finds up to 11 percent of patients had lung scarring after COVID-19 infection that may get worse over time. Credit: ATSIn a new study published online in the

Updated on: February 01,2024 17

Study reveals extent of residual lung damage after COVID-19 hospitalization

by American Thoracic SocietyNew study finds up to 11 percent of patients had lung scarring after COVID-19 infection that may get worse over time. Credit: ATSIn a new study published online in the

Updated on:February 01,2024 17